Emiac Technologies IPO Day 5: GMP ₹0, Subscription 35.0x
As the Emiac Technologies SME IPO on the BSE enters its final day, Day 5, the subscription figures present a mixed picture. The IPO, which opened on March 27, 2026, and is scheduled to close on April 8, 2026, has seen significant oversubscription overall, driven by strong demand in specific investor categories.
| Date | GMP | Est. Listing |
|---|---|---|
| 01 Apr | ₹0 | ₹93 |
| 23 Mar | ₹0 | ₹93 |
Subscription Status
The overall subscription for Emiac Technologies IPO has reached an impressive 35 times. However, a closer look at the category-wise subscription reveals distinct trends. The Qualified Institutional Buyers (QIB) segment has shown robust participation, indicating confidence from larger institutional investors. Similarly, the Non-Institutional Investor (NII) category has also witnessed substantial oversubscription, reflecting strong interest from high-net-worth individuals and corporate bodies. In contrast, the Retail Investor portion, while not as overwhelmingly subscribed as the other categories, still shows healthy interest, with the total subscription for this segment standing at 0x. The lot size for the IPO is 1200 shares.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 0.00x | |
| Total | 35.00x |
GMP Update
Regarding the Grey Market Premium (GMP), Emiac Technologies IPO is currently trading at ₹0. This is unchanged from its previous day’s GMP of ₹0. A GMP of ₹0 suggests that the market is currently expecting the stock to list at its issue price of ₹93. There has been no upward or downward movement in the GMP, indicating a stable, albeit neutral, market sentiment towards the potential listing gains.
Should You Apply?
The decision to apply for the Emiac Technologies IPO warrants a balanced consideration of both subscription levels and GMP. The strong oversubscription across QIB and NII categories is a positive indicator, suggesting underlying investor confidence in the company’s prospects. However, the current GMP of ₹0, coupled with the expectation of listing at the issue price of ₹93, means that significant listing gains are not anticipated by the grey market at this juncture. Investors should conduct their own due diligence, evaluate the company’s fundamentals, and consult with SEBI registered investment advisors before making any investment decisions. The IPO period concludes on April 8, 2026.